Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacs

Showing results (541-550 of 743) with videos related to

Pageof 75
Sort By:
Journal of Paediatrics and Child Health|September 16, 2004
Comprehensive health assessment for newly arrived refugee children in AustraliaN Davidson, S Skull, G Chaney, et al.
Internal Medicine Journal|February 21, 2008
Guidelines for the prevention of sepsis in asplenic and hyposplenic patientsD Spelman, J Buttery, A Daley, et al.
The Prostate|April 26, 2006
Germline ATBF1 mutations and prostate cancer riskJunyan Xu, Jurga Sauvageot, Charles M Ewing, et al.
Frontiers in Immunology|July 24, 2019
IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector FunctionLaura A Ridgley, Amy E Anderson, Nicola J Maney, et al.
BMJ Open|April 16, 2024
Operational complexities in international clinical trials: a systematic review of challenges and proposed solutionsLeher Gumber, Opeyemi Agbeleye, Alex Inskip, et al.
Rheumatology (Oxford, England)|May 13, 2025
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritisStephanie F Ling, Chuan Fu Yap, Nisha Nair, et al.
The Prostate|May 27, 1999
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancerE P Wilkens, D Freije, J Xu, et al.
Clinical and Experimental Immunology|November 21, 1997
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory diseaseJ D Isaacs, N Burrows, M Wing, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Diabetes Care|September 10, 1999
Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosisG E Umpierrez, W Woo, W A Hagopian, et al.
Pageof 75

Showing results (541-550 of 743) with videos related to

Sort By:
Pageof 75
Journal of Paediatrics and Child Health|September 16, 2004
Comprehensive health assessment for newly arrived refugee children in AustraliaN Davidson, S Skull, G Chaney, et al.
Internal Medicine Journal|February 21, 2008
Guidelines for the prevention of sepsis in asplenic and hyposplenic patientsD Spelman, J Buttery, A Daley, et al.
The Prostate|April 26, 2006
Germline ATBF1 mutations and prostate cancer riskJunyan Xu, Jurga Sauvageot, Charles M Ewing, et al.
Frontiers in Immunology|July 24, 2019
IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector FunctionLaura A Ridgley, Amy E Anderson, Nicola J Maney, et al.
BMJ Open|April 16, 2024
Operational complexities in international clinical trials: a systematic review of challenges and proposed solutionsLeher Gumber, Opeyemi Agbeleye, Alex Inskip, et al.
Rheumatology (Oxford, England)|May 13, 2025
Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritisStephanie F Ling, Chuan Fu Yap, Nisha Nair, et al.
The Prostate|May 27, 1999
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancerE P Wilkens, D Freije, J Xu, et al.
Clinical and Experimental Immunology|November 21, 1997
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory diseaseJ D Isaacs, N Burrows, M Wing, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Diabetes Care|September 10, 1999
Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosisG E Umpierrez, W Woo, W A Hagopian, et al.
Pageof 75